HETERO LABS

Company Type: Manufacturer

Company Introduction:

Hetero Labs Limited is a prominent Indian pharmaceutical company and one of the world's largest generic drug manufacturers. Established in 1993, Hetero is a vertically integrated pharmaceutical organization primarily engaged in research and development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), Finished Dosage Formulations, and Biosimilars.

Key aspects of Hetero Labs include:

- It operates numerous state-of-the-art manufacturing facilities across India, many of which are approved by global regulatory agencies such as the US FDA, EU GMP, and WHO GMP.

- The company possesses a diverse product portfolio spanning various therapeutic areas, including HIV/AIDS, oncology, cardiovascular, neurology, nephrology, urology, diabetes, hepatology, and immunology.

- Hetero has a significant global footprint, exporting its products to over 145 countries worldwide.

- It is recognized for its commitment to making essential medicines accessible and affordable, particularly in developing nations, and is a major producer of antiretroviral drugs.

Hetero Labs manufactures and sells a diverse range of pharmaceutical products. These can be broadly categorized into Active Pharmaceutical Ingredients (APIs), Finished Dosage Formulations, and Biologics.

For Finished Dosage Formulations, Hetero Labs offers products across numerous therapeutic areas. These include:

Antiretrovirals (ARVs)

They produce key medicines for HIV treatment such as Dolutegravir, Tenofovir Alafenamide, Efavirenz, Lopinavir Ritonavir, Darunavir, Raltegravir, Atazanavir, Ritonavir, and various combination therapies like Bictegravir Emtricitabine Tenofovir Alafenamide.

Oncology

Hetero Labs provides a wide array of products for cancer treatment, encompassing both cytotoxic chemotherapy and targeted therapies for various types of cancer.

Hepatology

Their portfolio includes treatments for liver diseases, notably Hepatitis C, with products like Sofosbuvir, Daclatasvir Sofosbuvir, and Ledipasvir Sofosbuvir combinations.

Cardiovascular

They offer medications for heart and circulatory conditions.

Neurology

Products for neurological disorders are part of their offerings.

Nephrology

Hetero Labs provides treatments for kidney related conditions.

Gastroenterology

Medicines for digestive system disorders are also produced.

Urology

They manufacture products for conditions affecting the urinary system.

Dermatology

Their range includes topical and systemic treatments for various skin conditions.

Pain Management

Analgesics and anti-inflammatory drugs are available for pain relief.

Anti-Diabetic

They produce medications for the management of diabetes.

Anti-Infectives

This category includes a broad spectrum of antibiotics, antivirals (such as Remdesivir and Favipiravir, particularly noted during the COVID-19 pandemic), and antifungals like Posaconazole.

Respiratory

Treatments for respiratory conditions are part of their product line.

Immunology

They offer immunomodulatory drugs.

Active Pharmaceutical Ingredients (APIs)

Hetero Labs is a significant manufacturer of Active Pharmaceutical Ingredients, supplying a vast number of APIs across various therapeutic categories to pharmaceutical companies worldwide for the production of finished drugs.

Biologics

The company also develops and markets biosimilar products and other complex biological drugs.